“Medical-Legal Issues in the Era of COVID-19,” a Zoom discussion hosted by Joe Sardano, president and chief executive officer of Sensus Healthcare, and David Goldberg, MD, JD, director of Skin Laser & Surgery Specialists of New York and New Jersey, will take place June 18 at 3:00 pm EST.

This is the third in a series of topical discussions Sensus is holding on the Zoom platform for its customers to highlight the views of leading dermatologists on the use of superficial radiation therapy (SRT) and other topics during this global pandemic.

Goldberg is recognized nationally and internationally for his work with skin lasers, cosmetic dermatology and non-invasive facial and body rejuvenation techniques. A board-certified dermatologist who has been in practice since 1985, he has treated patients and taught doctors throughout the world on the use of these cutting-edge technologies.

Topics will include:

  • Basic principles of negligence and protecting oneself against medical malpractice in the use of SRT in the COVID-19 era.
  • Office employment issues during COVID-19.    ​
  • Use of telemedicine in general and specifically for SRT patients, including a focus on telemedicine billing and avoiding an audit.

“The response to our first two Zoom events was outstanding, and we are delighted to facilitate a conversation between our customers on important topics related to dermatology clinics and best practices for patient care, especially now as many regions across the US are starting to open up,” Sardano says, in a media release.

“In the current environment, more than ever SRT is providing a valuable option for non-melanoma skin cancer as the treatment is very fast – patients are in and out of the clinic in minutes – and there is no risk of infection that may occur with Mohs surgery.

“We expect to continue hosting these programs for the foreseeable future given the positive feedback we have received of their value,” Sardano adds.

Advance registration for this event is required. A replay of the program will be posted the Sensus Healthcare’s website a few days after the program, according to the release.

[Source(s): Sensus Healthcare, GlobeNewswire]